Pfizer booth at AACR 2026
Biotech

Pfizer’s $2.3B bet ends in failure as CD47 blocker scrapped

The Big Pharma has abandoned the second and final clinical-stage candidate from the Trillium acquisition.
James Waldron May 5, 2026 9:15am
end of the road road block shut down closed blocked

Blocked by FDA, Passage cuts headcount by 75%

May 4, 2026 1:33pm
Spiral helical welded steel pipe

Vertex drops Moderna-partnered inhaled CF candidate

May 4, 2026 5:48pm
Trump signing psychedelic executive order in Oval Office with Marty Makary RFK Jr Joe Rogan and some other guy behind im

‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics

May 4, 2026 3:30am
Becraft

Strand Tx CEO Jake Becraft weighs in on FDA's IND reform, China

May 4, 2026 12:00pm
White arrow on a road pointing to the rising sun

Avalo’s phase 2 win fuels AbbVie chase despite placebo headwind

May 6, 2026 6:00am
More News

‘No change’ for CagriSema as Novo ditches single-chamber device

May 6, 2026 4:40am

After buyout, Gilead is laying off Arcellx staff in California

May 5, 2026 3:12pm

Madrigal boosts MASH pipeline with $1B biobucks Arrowhead deal

May 5, 2026 10:40am

Fierce Biotech Fundraising Tracker '26: Cytospire & more

May 5, 2026 10:15am